Why is the comparison with Medicare for LEVOBUNOLOL 0.5% EYE DROPS labelled estimated?

Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Levobunolol HCl / Levobunolol HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.

Why does this page start at 5 mL?

NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for this product’s NDC (“1 BOTTLE, DROPPER in 1 CARTON (24208-505-05) / 5 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 5 ML. Change it to match your prescription.

LEVOBUNOLOL 0.5% EYE DROPS

For 5 mL

Pharmacies pay

$14.09 filed

5 × $2.81863 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$14.64 filed

5 × $2.92837 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

1.0× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Levobunolol HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$21.20 estimated

$14.09 + $2.11 (15%) + $5.00 fee per fill = $21.20

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LEVOBUNOLOL 0.5% EYE DROPS is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levobunolol hydrochloride.

FDA gives its dosage form as solution/ drops and its route as ophthalmic.

The labeler, the company named on the label, is Bausch & Lomb Incorporated.

FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 24208-0505-05.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $14.09 for 5 mL (5 × $2.81863 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

The NDC

24208-0505-05 · Bausch & Lomb Incorporated · $2.81863 per ML · eff. 2026-09-23 filed

Compared with its class

Its NADAC price is $2.81863 per ML filed.

Of the 19 other products in FDA’s beta-Adrenergic Blocker class priced per ML, 11 have a higher middle NADAC price and 8 a lower one. The one in the middle is TIMOLOL 0.5% GEL-SOLUTION, at $8.30197 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $14.64 for 5 mL, at an average of $2.92837 per ML in 2024 (2024-01-01 to 2024-12-31) for “Levobunolol HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 52,530 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.

Questions

Why is the comparison with Medicare for LEVOBUNOLOL 0.5% EYE DROPS labelled estimated?: Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Levobunolol HCl / Levobunolol HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 5 mL?: NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for this product’s NDC (“1 BOTTLE, DROPPER in 1 CARTON (24208-505-05) / 5 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 5 ML. Change it to match your prescription.

Its pharmacologic class

beta-Adrenergic Blocker 98 products